-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Alvotech, Lowers Price Target to $4

Benzinga·03/24/2026 14:03:34
Listen to the news
Barclays analyst Glen Santangelo maintains Alvotech (NASDAQ:ALVO) with a Underweight and lowers the price target from $5 to $4.